Pearltrader

 
 
 
Login Forgot your password?

Create new account

Farsight Bioscience Limited / Ranking / (WKN: A1JD8Y)

Rating   Category
33%  

Estimation of Market Cap

overvalued, realistic, undervalued
33%  

Management

experienced & ambitious, suitable for the company
33%  

News (Quality)

Qualitative not top quality, adequate, first-class
33%  

News (Quantity)

Quantitative not top quality, adequate, first-class
33%  

Businessmodel

not profitable, lucrative, excellent marketpositions
33%  

Branche

market is saturated, stagnative market, excellent marketposition is supposable
33%  

Investor Relations

External Presentations
33%  

Website

informative, qualitative & opitcal high class
33%  

Chart developement

Stock price at a loss, stagnated, gained value
33%  

1 user ranked this company

 

User who ranked the company

Date Time Username Rating
31.10.2011 18.53

dennisCsweet

33%